Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : CellularVision (CVUS): 2-way LMDS wireless cable. -- Ignore unavailable to you. Want to Upgrade?

To: Karl Schwarszchild who wrote (1539)	3/16/1998 3:09:00 AM
From: Karl Schwarszchild	Read Replies (2) \| Respond to of 2063

I seem to remember reading somewhere (???) about a $10M line of credit held in reserve, as an alternative, in lieu of, or in addition to the pending $40M line. Not sure - checking... At any rate, principals are effective deal makers over many years and are well capable of accessing capital. I am not worried about company securing funding as necessary. ... With respect once again to the recent WSJ article, for the record I would like to say that I found it incredibly shortsighted. I thought the "analysis" offered was inappropriate and revealed a lack of understanding about the technology involved. For one thing, statements were made concerning company "performance" as if Cellularvision were an entity which had already brought its business plan to some fruition! To the contrary, Cellularvision is still in many ways a development stage concern, an enterprise only barely born. As Shant was quoted saying, "It is only the beginning." Bringing the "business plan" to fruition has necessarily had to await recent technological, manufacturing, industry and regulatory advances. Now that many of those advances have happened, now that equipment costs are down and capabilities are up, now that spectrum is being licensed nationally, now that big name consolidation of the LMDS industry has occurred, and is occurring, CVUS can go forward and realize its potential as never before! The data product now being deployed is a big part of that ultimate potential and is sure to be a hit in NYC where there is almost NO cost effective alternative for bandwidth-starved individuals and small offices at this time. With suitable marketing, the biggest problem Cellularvision faces going forward is meeting demand. Anyway, to conclude with a usual refrain... The non value-added, unimproved Boston A block is now going for $8.28/pop. I'll say, then, that the NYC A block is _conservatively_ worth $9.00/pop x 8.6m pops means CVUS is worth at least ~$75m license + $12m equity = $87m = $5.44/share. Have a good week all.